Physician profile
Robert R Low
NPI 1881761989
$793.46
in general payments reported to CMS, 2019-2025
12 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2021: $256 · 2022: $64.07 · 2023: $31.36 · 2024: $72.88 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.06 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $351.11 | 2019-2021 | |
| Novo Nordisk INC | $75.73 | 2019-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $67.31 | 2024-2025 | Capvaxive |
| Lilly USA, LLC | $53.03 | 2019-2024 | Jardiance |
| Amgen INC. | $42.95 | 2022-2023 | Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $41.11 | 2021-2022 | |
| Apria Healthcare LLC | $38.96 | 2021 | |
| Astellas Pharma US INC | $35.51 | 2019 | |
| Esperion Therapeutics, INC. | $33.19 | 2021-2024 | Nexletol |
| Dexcom, INC. | $28.62 | 2021-2022 | |
| Exact Sciences Corporation | $13.61 | 2024 | Cologuard Collection Kit |
| Eisai INC. | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Low listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.